AlzeCure gets Presentation Accepted on Disease-Modifying Effects of ACD856 at Alzheimer’s Conference
STOCKHOLM, SE / ACCESSWIRE / September 26, 2023 / AlzeCure Pharma (STO:ALZCUR)(FRA:AC6) AlzeCure Pharma AB (publ) (FN STO: ALZCUR), a...
News
FendX Engages Independent Trading Group (ITG), Inc. for Market Making Services and Engages Longtable Capital Partners for IR Services
Oakville, Ontario--(Newsfile Corp. - September 25, 2023) - FendX Technologies Inc. (CSE: FNDX) (OTCQB: FDXTF) (FSE: E8D) (the "Company" or...
NextGen Healthcare Supports Athletico Physical Therapy’s Growing Footprint
One of Nation’s Largest Physical Therapy Networks Enters New Markets, Doubles Down on Healthcare Software SolutionREMOTE-FIRST COMPANY/CHICAGO--(BUSINESS WIRE)--$NXGN #NextGenHealthcare--NextGen Healthcare,...
FDA Announces Formal Support for Voluntary Improvement Program (VIP)
The first Case for Quality program to be supported by FDA via final guidance is set to expandSCHAUMBURG, Ill.--(BUSINESS WIRE)--#isaca--The...
Rho to Lead U.S. Clinical Trials for Next Generation of COVID-19 Vaccines as Part of $5 Billion NextGen Initiative
RESEARCH TRIANGLE PARK, NC / ACCESSWIRE / September 25, 2023 / The U.S. Department of Health and Human Services (HHS)...
The Assistance Fund Opens New Program for Epidermolysis Bullosa
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Epidermolysis BullosaORLANDO, FL / ACCESSWIRE / September...
Florence Healthcare Acquires VersaTrial to Accelerate Clinical Research Site Enablement
Florence Healthcare, the leading provider of Site Enablement Platforms for clinical trials, announced today that it has acquired VersaTrial, a...
Sight360 Unveils Exciting New Optical Hub, Marking a Milestone Expansion Within the Tampa Bay Area
TAMPA, FL / ACCESSWIRE / September 25, 2023 / Sight360 is thrilled to announce the opening of an expanded optical...
DirectTrust Releases New 2024 Accreditation Criteria Versions for Public Review through November 28
Criteria enhancements include those for 19 existing programs; updates address the elimination of criteria redundancies across several programs as well...
myBenefits.ai Welcomes Edward Marx and Paolo Zambito to the Advisory Team
PORTOLA VALLEY, Calif.--(BUSINESS WIRE)--myBenefits.ai, an AI-powered platform for personalized post-discharge instructions, streamlined communication, and convenient healthcare support, announced today that...
Pilot Study demonstrates Vapotherm HVNI technology is more effective than standard oxygen therapy for treatment of acute asthma in children
EXETER, N.H.--(BUSINESS WIRE)--Vapotherm, Inc. (NYSE: VAPO), a global medical technology company focused on the development and commercialization of its proprietary...
NervGen Pharma Announces First Subject Dosed in Landmark Phase 1b/2a Clinical Trial for NVG-291 in Spinal Cord Injury
Chronic spinal cord injury cohort results expected in mid-2024 Subacute spinal cord injury cohort results expected in late 2024/early 2025Vancouver,...
HPC Announced ‘HPC ROCKS COEUR D’ALENE’ Event During 2023 MCRA Annual Conference
HPC recently hosted its annual 'HPC ROCKS COEUR D'ALENE' Event at the 2023 MCRA Annual Conference.COEUR D'ALENE, ID / ACCESSWIRE...
Ainos Announces Placement of Initial $3 Million Tranche of $10 Million Private Placement
Proceeds to fund company's clinical trials, commercial product launch, and working capital Initial conversion price set at $1.50 per shareSAN...
New Campaign from Arcutis Aims to Educate, Raise Awareness, and Provide Encouragement for Those Living with Seborrheic Dermatitis
WESTLAKE VILLAGE, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT), an early commercial-stage company focused on...
Scilex Holding Company announces the State of Indiana Medicaid will add Elyxyb as a preferred agent to its preferred drug list (PDL) effective October 1, 2023
PALO ALTO, Calif., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue-generating...
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
Caren Deardorf Editas Medicine, today announced the appointment of Caren Deardorf as the Company’s first Chief Commercial and Strategy Officer.CAMBRIDGE,...
Inovalon to Host Customer Congress in Washington, D.C. October 15-17, 2023
Healthcare Leaders to Convene in Washington, D.C. to Explore Data and Machine Learning’s Impact on Patient Outcomes and EconomicsBOWIE, Md.,...
PharmAla Receives First Office Action for PharmAla-1 PCT Filing
PCT Examiner Finds Molecule to be both Novel and InventiveVANCOUVER, British Columbia, Sept. 25, 2023 (GLOBE NEWSWIRE) -- PharmAla Biotech...
Regeneron Completes Acquisition of Decibel Therapeutics, Adding Promising Gene Therapy Programs for Hearing Loss
TARRYTOWN, N.Y., Sept. 25, 2023 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that it has successfully completed...